TSHA
Taysha Gene Therapies, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -5.3% ·
aliran saham +9.6% ·
posisi baru bersih -5.6%
· formula
Akumulasi terkonsentrasi: saham yang meningkat di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 146.63M | $997.93M | +12 | −5 |
| Q1 2026 | 81 | -9 | 130.93M | $584.01M | +4 | −14 |
| Q4 2025 | 90 | 0 | 135.71M | $746.41M | +2 | −1 |
| Q3 2025 | 18 | -1 | 108.64M | $355.25M | n/a | −1 |
| Q2 2025 | 16 | +5 | 65.80M | $152.01M | +5 | n/a |
| Q1 2025 | 8 | -4 | 14.26M | $19.83M | +1 | −5 |
| Q4 2024 | 12 | +5 | 19.11M | $33.06M | +5 | n/a |
| Q3 2024 | 6 | 0 | 7.50M | $15.08M | +2 | −2 |
| Q2 2024 | 6 | n/a | 5.37M | $12.04M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 19.31M | n/a | $63.14M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (pasif) | 16.36M | +23.0% | $53.51M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 3 | Fidelity (FMR) ✦ | 14.59M | -6.6% | $47.72M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 4 | Goldman Sachs Group ✦ | 13.38M | n/a | $43.76M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | The Vanguard Group ✦ (pasif) | 12.85M | +17.9% | $42.02M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 6 | Point72 Asset Management ✦ | 7.33M | +0.2% | $23.97M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (pasif) | 7.24M | +40.8% | $23.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasif) | 5.17M | +36.4% | $16.92M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 4.03M | +37.1% | $13.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 3.33M | -31.2% | $10.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 2.71M | +574.1% | $8.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 592.49K | n/a | $1.94M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 13 | Wellington Management ✦ | 568.01K | -10.7% | $1.86M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 14 | Marshall Wace ✦ | 476.87K | +499.9% | $1.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 367.31K | -30.6% | $1.20M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | AQR Capital Management ✦ | 151.00K | +11.2% | $493,769 | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 17 | T. Rowe Price ✦ | 113.83K | +34.5% | $373,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 66.11K | +102.3% | $216,163 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Renaissance Technologies | $126,819 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 190 pemegang, 265.00M saham, $1.21B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.